FDA approves new painkiller that shows promise and challenges of opioid alternatives
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
WBUR4d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals ... It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering ...
Indiatimes3d
US FDA approves new painkiller Journavx as alternative to opioids
approved Vertex Pharmaceuticals' drug, Journavx, for short-term pain relief following surgery or injuries. This is the first new pharmaceutical approach to pain treatment in over 20 years ...
Nasdaq4d
FDA Approves Vertex Pharma's JOURNAVX As The First Drug In A New Class Of Non-Opioid Pain Medicines
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX ... oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years. The most recent pain medication approved ...
Oregonian4d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternative
It’s the first new pharmaceutical approach to treating pain in more than 20 ... many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex ...
Asheville Citizen-Times21d
Asheville named in New York Times top 20 travel destinations for 2025
Asheville, North Carolina has been placed in the top 20 on a list of 52 travel destinations for 2025 by the New York Times. The city, which was ranked No. 16 on the list, joins worldwide ...